| Autor: |
Barreiro-Pérez M; Cardiology Department, Galicia Sur Health Research Institute (IISGS), University Hospital Alvaro Cunqueiro, 36213 Vigo, Spain., González-Ferreiro R; Cardiology Department, Galicia Sur Health Research Institute (IISGS), University Hospital Alvaro Cunqueiro, 36213 Vigo, Spain., Caneiro-Queija B; Cardiology Department, Galicia Sur Health Research Institute (IISGS), University Hospital Alvaro Cunqueiro, 36213 Vigo, Spain., Tavares-Silva M; Cardiology Department, Galicia Sur Health Research Institute (IISGS), University Hospital Alvaro Cunqueiro, 36213 Vigo, Spain., Puga L; Cardiology Department, Galicia Sur Health Research Institute (IISGS), University Hospital Alvaro Cunqueiro, 36213 Vigo, Spain., Parada-Barcia JA; Cardiology Department, Galicia Sur Health Research Institute (IISGS), University Hospital Alvaro Cunqueiro, 36213 Vigo, Spain., Rodriguez-Perez A; Cardiology Department, Galicia Sur Health Research Institute (IISGS), University Hospital Alvaro Cunqueiro, 36213 Vigo, Spain., Baz-Alonso JA; Cardiology Department, Galicia Sur Health Research Institute (IISGS), University Hospital Alvaro Cunqueiro, 36213 Vigo, Spain., Pinon-Esteban MA; Cardiac Surgery Department, Galicia Sur Health Research Institute (IISGS), University Hospital Alvaro Cunqueiro, 36213 Vigo, Spain., Estevez-Loureiro R; Cardiology Department, Galicia Sur Health Research Institute (IISGS), University Hospital Alvaro Cunqueiro, 36213 Vigo, Spain., Iniguez-Romo A; Cardiology Department, Galicia Sur Health Research Institute (IISGS), University Hospital Alvaro Cunqueiro, 36213 Vigo, Spain. |
| Abstrakt: |
Tricuspid regurgitation (TR) is one of the most common heart valve diseases, associated a with poor prognosis since significant TR is associated with an increased mortality risk compared to no TR or mild regurgitation. Surgery is the standard treatment for TR, although it is associated with high morbidity, mortality, and prolonged hospitalization, particularly in tricuspid reoperation after left-sided surgery. Thus, several innovative percutaneous transcatheter approaches for repair and replacement of the tricuspid valve have gathered significant momentum and have undergone extensive clinical development in recent years, with favorable clinical outcomes in terms of mortality and rehospitalization during the first year of follow-up. We present three clinical cases of transcatheter tricuspid valve replacement in an orthotopic position with two different innovative systems along with a review of the state-of-the-art of this emergent topic. |
